TNSN98024A1 - 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant. - Google Patents

2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.

Info

Publication number
TNSN98024A1
TNSN98024A1 TNTNSN98024A TNSN98024A TNSN98024A1 TN SN98024 A1 TNSN98024 A1 TN SN98024A1 TN TNSN98024 A TNTNSN98024 A TN TNSN98024A TN SN98024 A TNSN98024 A TN SN98024A TN SN98024 A1 TNSN98024 A1 TN SN98024A1
Authority
TN
Tunisia
Prior art keywords
substitue
preparation
pharmaceutical compositions
compositions containing
pyridines
Prior art date
Application number
TNTNSN98024A
Other languages
English (en)
Inventor
Nowakowski Jolanta
Adams Lowe John Iii
Alfred Volkmann Robert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN98024A1 publication Critical patent/TNSN98024A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE.DANS LAQUELLE G, R1 ET R2 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DANS LE TRAITEMENT ET LA PREVENTION D'AFFECTIONS DU SYSTEME NERVEUX CENTRAL ET D'AUTRES MALADIES
TNTNSN98024A 1997-02-10 1998-02-09 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant. TNSN98024A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3753397P 1997-02-10 1997-02-10

Publications (1)

Publication Number Publication Date
TNSN98024A1 true TNSN98024A1 (fr) 2005-03-15

Family

ID=21894849

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98024A TNSN98024A1 (fr) 1997-02-10 1998-02-09 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.

Country Status (44)

Country Link
US (2) US20010007873A1 (fr)
EP (1) EP0958282B1 (fr)
JP (1) JP3505189B2 (fr)
KR (1) KR100460399B1 (fr)
CN (3) CN1246848A (fr)
AP (1) AP833A (fr)
AR (1) AR011117A1 (fr)
AT (1) ATE271544T1 (fr)
AU (1) AU744313B2 (fr)
BG (1) BG103633A (fr)
BR (1) BR9811093A (fr)
CA (1) CA2277990C (fr)
CO (1) CO4920225A1 (fr)
CZ (1) CZ292135B6 (fr)
DE (1) DE69825147T2 (fr)
DK (1) DK0958282T3 (fr)
DZ (1) DZ2414A1 (fr)
EA (1) EA003834B1 (fr)
ES (1) ES2224354T3 (fr)
GT (1) GT199800032A (fr)
HN (1) HN1998000030A (fr)
HR (1) HRP980069A2 (fr)
HU (1) HUP0000762A3 (fr)
IL (1) IL130898A0 (fr)
IS (1) IS5118A (fr)
MA (1) MA27676A1 (fr)
MY (1) MY120976A (fr)
NO (1) NO314803B1 (fr)
NZ (2) NZ518345A (fr)
OA (1) OA11084A (fr)
PA (1) PA8446301A1 (fr)
PE (1) PE58599A1 (fr)
PL (1) PL335161A1 (fr)
PT (1) PT958282E (fr)
SI (1) SI0958282T1 (fr)
SK (1) SK101199A3 (fr)
TN (1) TNSN98024A1 (fr)
TR (1) TR199901917T2 (fr)
TW (1) TW458969B (fr)
UA (1) UA64740C2 (fr)
UY (1) UY24881A1 (fr)
WO (1) WO1998034919A1 (fr)
YU (1) YU35699A (fr)
ZA (1) ZA981017B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010049379A1 (en) 1997-08-27 2001-12-06 Lowe John Adams 2-aminopyridines containing fused ring substituents
ID27027A (id) * 1998-06-03 2001-02-22 Pfizer Prod Inc 2-aminopiridin yang mengandung substituen cincin lebur
WO2000009130A2 (fr) * 1998-08-11 2000-02-24 Pfizer Products Inc. Nouvelles utilisations pharmaceutiques pour les inhibiteurs de nos
SE9803710L (sv) 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
US7115557B2 (en) 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
KR20010114213A (ko) 1999-02-25 2001-12-31 실버스타인 아써 에이. 접합 고리 치환기를 함유한 2-아미노피리딘
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
GB0019006D0 (en) * 2000-08-04 2000-09-20 Astrazeneca Ab Novel compounds
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US20030232739A1 (en) * 2001-08-15 2003-12-18 Pfizer Inc. Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
US6803470B2 (en) 2001-10-10 2004-10-12 Pfizer Inc 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
DOP2002000467A (es) * 2001-10-10 2003-04-15 Pfizer Prod Inc 2-amino-6 (fenilo sustituido en las posiciones 2,4,5)-piridinas
US7045652B2 (en) * 2002-07-03 2006-05-16 Pfizer Inc Processes for preparing substituted aryl boronic acids
US20040092741A1 (en) * 2002-11-08 2004-05-13 Pfizer Inc Substituted pyridines via boronic acid coupling
WO2005007627A1 (fr) * 2003-07-18 2005-01-27 Nihon Nohyaku Co., Ltd. Derive de phenylpyridine, produit intermediaire correspondant, et herbicide contenant ledit derive de phenylpyridine en tant qu'ingredient actif
EP1850838A2 (fr) * 2005-02-21 2007-11-07 Proximagen Ltd. Inhibition ou traitement de la dyskinesie
GB0607196D0 (en) * 2006-04-11 2006-05-17 Prosidion Ltd G-protein coupled receptor agonists
AR064572A1 (es) * 2006-12-28 2009-04-08 Basf Ag Derivados de piridina 2-sustituidas, una composicion farmaceutica que las comprende y su uso en la preparacion de un medicamento para el tratamiento del cancer.
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
CN105209448B (zh) 2013-02-28 2018-09-14 株式会社蒂奥姆生物 三环化合物及其用途
AU2014346483B2 (en) * 2013-11-07 2019-01-17 The University Of Kansas Biphenylamide derivative Hsp90 inhibitors
RU2017107455A (ru) * 2014-08-13 2018-09-13 Мейдзи Сейка Фарма Ко., Лтд. Кристаллические средства против трихофитона и способ их получения
CN106265640B (zh) * 2016-08-11 2019-05-14 吉林大学 Appa在制备治疗糖尿病肾病药物中的应用
CN108069831B (zh) * 2018-01-25 2020-11-24 上海恩氟佳科技有限公司 一种合成2,3-二甲基-4-氟苯酚的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5704594A (en) * 1992-12-18 1994-07-19 Wellcome Foundation Limited, The Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
US5854234A (en) * 1993-10-21 1998-12-29 G. D. Searle & Co. Amidino dervatives useful as nitric oxide synthase inhibitors
WO1996018616A1 (fr) * 1994-12-12 1996-06-20 Merck & Co., Inc. 2-aminopyridines substituees utilisees comme inhibiteurs de synthase d'oxyde d'azote
PT891332E (pt) * 1996-03-29 2004-07-30 Pfizer Derivados de 6-fenilpiridil-2-amina

Also Published As

Publication number Publication date
YU35699A (sh) 2002-06-19
CN1246848A (zh) 2000-03-08
CN1523015A (zh) 2004-08-25
BR9811093A (pt) 2000-07-18
CN1515554A (zh) 2004-07-28
IL130898A0 (en) 2001-01-28
CZ292135B6 (cs) 2003-08-13
SK101199A3 (en) 2000-10-09
ATE271544T1 (de) 2004-08-15
PL335161A1 (en) 2000-04-10
AR011117A1 (es) 2000-08-02
CZ276999A3 (cs) 2000-05-17
MY120976A (en) 2005-12-30
HN1998000030A (es) 1998-10-22
OA11084A (en) 2002-03-15
WO1998034919A1 (fr) 1998-08-13
SI0958282T1 (en) 2005-02-28
US20010007873A1 (en) 2001-07-12
CO4920225A1 (es) 2000-05-29
JP2000509408A (ja) 2000-07-25
ES2224354T3 (es) 2005-03-01
JP3505189B2 (ja) 2004-03-08
NZ336623A (en) 2000-11-24
EA003834B1 (ru) 2003-10-30
UY24881A1 (es) 2000-12-29
KR100460399B1 (ko) 2004-12-08
KR20000070803A (ko) 2000-11-25
CA2277990A1 (fr) 1998-08-13
PT958282E (pt) 2004-11-30
DK0958282T3 (da) 2004-11-29
UA64740C2 (uk) 2004-03-15
MA27676A1 (fr) 2006-01-02
EP0958282B1 (fr) 2004-07-21
HUP0000762A3 (en) 2000-10-30
PE58599A1 (es) 1999-06-12
AP833A (en) 2000-05-10
CA2277990C (fr) 2006-08-01
NO314803B1 (no) 2003-05-26
DZ2414A1 (fr) 2003-01-04
NO993823D0 (no) 1999-08-09
ZA981017B (en) 1999-08-10
NO993823L (no) 1999-08-09
AU5572798A (en) 1998-08-26
GT199800032A (es) 1998-02-11
IS5118A (is) 1999-07-29
US20030162765A1 (en) 2003-08-28
DE69825147T2 (de) 2005-08-04
EA199900632A1 (ru) 2000-02-28
TW458969B (en) 2001-10-11
HRP980069A2 (en) 1998-12-31
PA8446301A1 (es) 2000-05-24
AU744313B2 (en) 2002-02-21
NZ518345A (en) 2005-02-25
EP0958282A1 (fr) 1999-11-24
TR199901917T2 (xx) 1999-12-21
BG103633A (bg) 2000-11-30
DE69825147D1 (de) 2004-08-26
HUP0000762A2 (hu) 2000-09-28

Similar Documents

Publication Publication Date Title
TNSN98024A1 (fr) 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
TNSN99169A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97192A1 (fr) Derives de pyrimidine bicycliques condenses, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98035A1 (fr) Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98022A1 (fr) DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
TNSN98150A1 (fr) Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99039A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99155A1 (fr) 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98154A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
TNSN99073A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN97055A1 (fr) Derives de 6-phenylpyridyl -2- amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97145A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99253A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98112A1 (fr) Composes dipeptidiques
TNSN99162A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant